These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 31846425)

  • 21. Increased circulating zonulin in children with biopsy-proven nonalcoholic fatty liver disease.
    Pacifico L; Bonci E; Marandola L; Romaggioli S; Bascetta S; Chiesa C
    World J Gastroenterol; 2014 Dec; 20(45):17107-14. PubMed ID: 25493023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum complement factor 5a levels are associated with nonalcoholic fatty liver disease in obese children.
    Hu W; Wang M; Yin C; Li S; Liu Y; Xiao Y
    Acta Paediatr; 2018 Feb; 107(2):322-327. PubMed ID: 28981167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infant nutrition and maternal obesity influence the risk of non-alcoholic fatty liver disease in adolescents.
    Ayonrinde OT; Oddy WH; Adams LA; Mori TA; Beilin LJ; de Klerk N; Olynyk JK
    J Hepatol; 2017 Sep; 67(3):568-576. PubMed ID: 28619255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thyroid dysfunction and hepatic steatosis in overweight children and adolescents.
    Kaltenbach TE; Graeter T; Oeztuerk S; Holzner D; Kratzer W; Wabitsch M; Denzer C
    Pediatr Obes; 2017 Feb; 12(1):67-74. PubMed ID: 26877190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The accuracy of fatty liver index for the screening of overweight and obese children for non-alcoholic fatty liver disease in resource limited settings.
    de Silva MHAD; Hewawasam RP; Kulatunge CR; Chamika RMA
    BMC Pediatr; 2022 Aug; 22(1):511. PubMed ID: 36042456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of anthropometric measurements for prediction of the atherosclerosis and liver histology in young adults with nonalcoholic fatty liver disease.
    Dogan T; Ozturk K; Celikkanat S; Aykan MB; Uygun A
    Eur J Gastroenterol Hepatol; 2019 Nov; 31(11):1460-1466. PubMed ID: 31045630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of neck circumference as an easy and reliable predictor for non-alcoholic fatty liver disease.
    Salmanroghani H; Salmanroghani R; Nourian M; Khayarn K; Lahmi F; Iravani S
    Turk J Gastroenterol; 2019 Feb; 30(2):163-170. PubMed ID: 30541716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Waist to height ratio: a simple screening tool for nonalcoholic fatty liver disease in obese children.
    Özhan B; Ersoy B; Özkol M; Kiremitci S; Ergin A
    Turk J Pediatr; 2016; 58(5):518-523. PubMed ID: 28621093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between neck circumference and non-alcoholic fatty liver disease: cross-sectional analysis from ELSA-Brasil.
    Santos LLM; Diniz MFHS; Goulart AC; Barreto SM; Figueiredo RC
    Sao Paulo Med J; 2022; 140(2):213-221. PubMed ID: 35043830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of non-alcoholic fatty liver disease in patients with diabetes mellitus, hyperlipidemia, obesity and polycystic ovary syndrome: A cross-sectional study in north of Iran.
    Mansour-Ghanaei F; Joukar F; Mobaraki SN; Mavaddati S; Hassanipour S; Sepehrimanesh M
    Diabetes Metab Syndr; 2019; 13(2):1591-1596. PubMed ID: 31336526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adverse metabolic phenotype of adolescent girls with non-alcoholic fatty liver disease plus polycystic ovary syndrome compared with other girls and boys.
    Ayonrinde OT; Adams LA; Doherty DA; Mori TA; Beilin LJ; Oddy WH; Hickey M; Sloboda DM; Olynyk JK; Hart R
    J Gastroenterol Hepatol; 2016 May; 31(5):980-7. PubMed ID: 26589977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk and protective factors of non-alcoholic fatty liver disease in paediatric obesity: A nationwide nested case-control study.
    Putri RR; Casswall T; Hagman E
    Clin Obes; 2022 Apr; 12(2):e12502. PubMed ID: 34873855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of clinical, endocrine and metabolic findings in obese children with and without hepatosteatosis.
    Basarir G; Ozcabi B; Aksu Sayman O; Ozturkmen Akay H; Yildiz FM
    J Pediatr Endocrinol Metab; 2021 Sep; 34(9):1081-1087. PubMed ID: 34142516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ferritin as a key risk factor for nonalcoholic fatty liver disease in children with obesity.
    Zhang J; Cao J; Xu H; Dong G; Huang K; Wu W; Ye J; Fu J
    J Clin Lab Anal; 2021 Feb; 35(2):e23602. PubMed ID: 33249617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Body Mass Index, Metabolic Health and Adipose Tissue Inflammation on the Severity of Non-alcoholic Fatty Liver Disease in Bariatric Surgical Patients: a Prospective Study.
    Ooi GJ; Burton PR; Bayliss J; Raajendiran A; Earnest A; Laurie C; Kemp WW; McLean CA; Roberts SK; Watt MJ; Brown WA
    Obes Surg; 2019 Jan; 29(1):99-108. PubMed ID: 30229460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gender differences in non-alcoholic fatty liver disease in obese children and adolescents: a large cross-sectional study.
    Jin B; Wu Z; Wang S; Yu Z; Ullah R; Liang X; Wu W; Huang K; Ni Y; Wang J; Dong G; Fu J
    Hepatol Int; 2024 Feb; 18(1):179-187. PubMed ID: 37861942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased asprosin is associated with non-alcoholic fatty liver disease in children with obesity.
    Liu LJ; Kang YR; Xiao YF
    World J Pediatr; 2021 Aug; 17(4):394-399. PubMed ID: 34370215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal analysis of risk of non-alcoholic fatty liver disease in adulthood.
    Cuthbertson DJ; Brown E; Koskinen J; Magnussen CG; Hutri-Kähönen N; Sabin M; Tossavainen P; Jokinen E; Laitinen T; Viikari J; Raitakari OT; Juonala M
    Liver Int; 2019 Jun; 39(6):1147-1154. PubMed ID: 30347485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The value of different insulin resistance indices in assessment of non-alcoholic fatty liver disease in overweight/obese children.
    El-Karaksy HM; El-Raziky MS; Fouad HM; Anwar GM; El-Mougy FM; El-Koofy NM; El-Hennawy AM
    Diabetes Metab Syndr; 2015; 9(2):114-9. PubMed ID: 25470627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-Alcoholic Fatty Liver Disease in Obese Youth With Insulin Resistance and Type 2 Diabetes.
    Scapaticci S; D'Adamo E; Mohn A; Chiarelli F; Giannini C
    Front Endocrinol (Lausanne); 2021; 12():639548. PubMed ID: 33889132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.